Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023:3:1103737.
doi: 10.3389/fviro.2023.1103737. Epub 2023 Mar 6.

Malignancy and viral infections in Sub-Saharan Africa: A review

Mahamadou Diakite  1 , Kathryn Shaw-Saliba  2 , Chuen-Yen Lau  3
Affiliations

Malignancy and viral infections in Sub-Saharan Africa: A review

Mahamadou Diakite et al. Front Virol. 2023.

Abstract

The burden of malignancy related to viral infection is increasing in Sub-Saharan Africa (SSA). In 2018, approximately 2 million new cancer cases worldwide were attributable to infection. Prevention or treatment of these infections could reduce cancer cases by 23% in less developed regions and about 7% in developed regions. Contemporaneous increases in longevity and changes in lifestyle have contributed to the cancer burden in SSA. African hospitals are reporting more cases of cancer related to infection (e.g., cervical cancer in women and stomach and liver cancer in men). SSA populations also have elevated underlying prevalence of viral infections compared to other regions. Of 10 infectious agents identified as carcinogenic by the International Agency for Research on Cancer, six are viruses: hepatitis B and C viruses (HBV and HCV, respectively), Epstein-Barr virus (EBV), high-risk types of human papillomavirus (HPV), Human T-cell lymphotropic virus type 1 (HTLV-1), and Kaposi's sarcoma herpesvirus (KSHV, also known as human herpesvirus type 8, HHV-8). Human immunodeficiency virus type 1 (HIV) also facilitates oncogenesis. EBV is associated with lymphomas and nasopharyngeal carcinoma; HBV and HCV are associated with hepatocellular carcinoma; KSHV causes Kaposi's sarcoma; HTLV-1 causes T-cell leukemia and lymphoma; HPV causes carcinoma of the oropharynx and anogenital squamous cell cancer. HIV-1, for which SSA has the greatest global burden, has been linked to increasing risk of malignancy through immunologic dysregulation and clonal hematopoiesis. Public health approaches to prevent infection, such as vaccination, safer injection techniques, screening of blood products, antimicrobial treatments and safer sexual practices could reduce the burden of cancer in Africa. In SSA, inequalities in access to cancer screening and treatment are exacerbated by the perception of cancer as taboo. National level cancer registries, new screening strategies for detection of viral infection and public health messaging should be prioritized in SSA's battle against malignancy. In this review, we discuss the impact of carcinogenic viruses in SSA with a focus on regional epidemiology.

Keywords: Sub-Saharan Africa (SSA); infection; malignancy; oncogenesis; virus.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. World Health Organization. Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. Geneva: World Health Organization; (2020).
    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin May (2021) 71(3):209–49. doi: 10.3322/caac.21660 - DOI - PubMed
    1. Reed FA, Tishkoff SA. African Human diversity, origins and migrations. Curr Opin Genet Dev (2006) 16(6):597–605. doi: 10.1016/j.gde.2006.10.008 - DOI - PubMed
    1. Paschou P, Lewis J, Javed A, Drineas P. Ancestry informative markers for fine-scale individual assignment to worldwide populations. research support, non-U.S. gov’t research support, U.S. gov’t, non-P.H.S. J Med Genet (2010) 47(12):835–47. doi: 10.1136/jmg.2010.078212 - DOI - PubMed
    1. Vogt PK. Retroviral oncogenes: a historical primer. Nat Rev Cancer (2012) 12(9):639–48. doi: 10.1038/nrc3320 - DOI - PMC - PubMed

LinkOut - more resources